These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 15335398

  • 21. Pathophysiology and treatment of hepatorenal syndrome.
    Wong F, Blendis L.
    Gastroenterologist; 1998 Jun; 6(2):122-35. PubMed ID: 9660529
    [Abstract] [Full Text] [Related]

  • 22. [Hepatorenal syndrome: pathogenesis and treatment].
    Ashkenazi E, Ilan Y, Shoval D.
    Harefuah; 2007 Jun; 146(6):475-9, 499. PubMed ID: 17760404
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.
    Moreau R, Lebrec D.
    Hepatology; 2006 Mar; 43(3):385-94. PubMed ID: 16496352
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Review article: pharmacological treatment of hepatorenal syndrome.
    Ginès P, Torre A, Terra C, Guevara M.
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():57-62; discussion 63-4. PubMed ID: 15335404
    [Abstract] [Full Text] [Related]

  • 27. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.
    Guevara M, Ginès P, Bandi JC, Gilabert R, Sort P, Jiménez W, Garcia-Pagan JC, Bosch J, Arroyo V, Rodés J.
    Hepatology; 1998 Aug; 28(2):416-22. PubMed ID: 9696006
    [Abstract] [Full Text] [Related]

  • 28. Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.
    Solà E, Ginès P.
    Dig Dis; 2015 Aug; 33(4):534-8. PubMed ID: 26159270
    [Abstract] [Full Text] [Related]

  • 29. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
    Guevara M, Ginès P, Fernández-Esparrach G, Sort P, Salmerón JM, Jiménez W, Arroyo V, Rodés J.
    Hepatology; 1998 Jan; 27(1):35-41. PubMed ID: 9425914
    [Abstract] [Full Text] [Related]

  • 30. [Diagnostics and therapy of hepatorenal syndrome. Recommendations of of the working group on portal hypertension of the Czech Hepatology Society and the J. E. Purkinje Czech Medical Society].
    Brůha R, Skupiny C, Balihar K, Drastich P, Hůlek P, Lata J, Petrtýl J, Procházka V, Spicák J, Vanásek T, Volfová M, Zdenek P, Czech Hepatology Society, J E Purkinje Czech Medical Society.
    Vnitr Lek; 2006 Jun; 52(6):649-50. PubMed ID: 16871772
    [Abstract] [Full Text] [Related]

  • 31. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V, Jiménez W.
    J Hepatol; 2000 Jun; 32(1 Suppl):157-70. PubMed ID: 10728802
    [Abstract] [Full Text] [Related]

  • 32. Hepatorenal syndrome.
    Bataller R, Ginès P, Guevara M, Arroyo V.
    Semin Liver Dis; 1997 Jun; 17(3):233-47. PubMed ID: 9308128
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Splanchnic and systemic vasodilatation: the patient.
    Tsai MH.
    J Clin Gastroenterol; 2007 Jun; 41 Suppl 3():S266-71. PubMed ID: 17975476
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Diagnosis and treatment of hepatorenal syndrome.
    Ginès P.
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):945-57. PubMed ID: 11139348
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.